OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
September 21, 2020
The study marks the first pharmacoepigenetic study in diabetes evaluating epigenetic factors as biomarkers to predict a drug’s effects on an individual.
The study evaluated COVID-19 patients within the epicenter of the COVID-19 pandemic in the United States.
September 08, 2020
Approval was based on a phase 3 clinical trial comparing the investigative doses with the approved 1.5 mg dose.
August 27, 2020
The removal of the boxed warning from canagliflozin was based on the FDA’s review of new data from 3 clinical trials.